A volunteer is given a shot of COVIVAC on March 23 (Photo: VNA)Hanoi (VNA) – Fifteen more volunteers have been inoculated
with Vietnam’s second homegrown candidate vaccine on March 23 as part
of its ongoing human trials.
The will be also injected into 15 other
volunteers on March 25.
Earlier on March 15, the first six out of the total 120
volunteers took their shots of the vaccine, with their overall health checked
on March 22. They are now in stable health conditions and doing their work as
normal.
All the volunteers will receive their second shots 28 days
after the first.
Developed by the Institute of Vaccines and Medical
Biologicals (IVAC) since last May, COVIVAC is the result of cooperation between
IVAC and a number of partners, including the Hanoi Medical University, the
Icahn School of Medicine at Mount Sinai in New York City, the University of
Texas in Austin, and the US-based health organisation PATH.
Using primary chicken embryo cell culture – a technique the
institute used previously to successfully produce seasonal flu vaccines – it is
the second “made-in-Vietnam” candidate vaccine tested on humans.
The Nanogen Pharmaceutical Biotechnology Company earlier
completed the first phase of human trials of its NanoCovax vaccine and began
the second phase on February 26./.
Source: VietnamPlus
